From: Sepsis 2019
 | Total (n = 97) | Sepsis (n = 51) | Septic shock (n = 46) | Controls (n = 46) |
---|---|---|---|---|
Age, median (range) | 75 (42-98) | 76 (42-98) | 74 (42-96) | 66 (35-79) |
Sex, n (%) | ||||
 Male | 54 (56) | 28 (55) | 26 (57) | 24 (52) |
 Female | 43 (44) | 23 (45) | 20 (43) | 22 (48) |
Infection site, n (%) | ||||
 Respiratory | 63 (64.9) | 33 (64.7) | 30 (65.2) |  |
 Genitourinary | 32 (33.0) | 19 (37.3) | 13 (28.3) |  |
 Cardiovascular | 3 (3.1) | 0 (0.0) | 3 (6.5) |  |
 Gastrointestinal | 2 (2.1) | 0 (0.0) | 2 (4.3) |  |
 Musculoskeletal | 2 (2.1) | 1 (2.0) | 1 (2.2) |  |
 Central Nervous | 1 (1.0) | 0 (0.0) | 1 (2.2) |  |
 Hepatobiliary | 1 (1.0) | 0 (0.0) | 1 (2.2) |  |
 Skin and soft tissue | 1 (1.0) | 1 (2.0) | 0 (0.0) |  |
 Unknown | 5 (5.2) | 2 (3.9) | 3 (6.5) |  |
Underlying disease | ||||
 Coronary artery disease | 11 (11.3) | 5 (9.8) | 6 (13.0) |  |
 Malignancy | 10 (10.3) | 4 (7.8) | 6 (13.0) |  |
 Rheumatic disease | 4 (4.1) | 2 (3.9) | 2 (4.3) |  |
SOFA score, median (IQR) | 8 (4-11) | 6 (3-9) | 10 (6-13) | Â |
APACHE II score, median (IQR) | 21 (13-30) | 18 (10-27) | 25 (16-35) | Â |
Laboratory value, median (IQR) or mean ± SEM | ||||
 Procalcitonin (ng/ml) | 1.6 (0.5-10.7) | 0.3 (0.2-1.2) | 3.4 (1.6-20.3) |  |
 CRP (mg/dL) | 10 (6-20) | 10 (5-20) | 11 (7-21) |  |
 Lactate (mmol/L) | 3.6 (2.6-4.6) | 1.9 (1.1-2.8) | 5.5 (3.6-7.5) |  |
 Creatinine (mg/dL) | 2.5 ± 0.2 | 2.1 ± 0.2 | 2.9 ± 0.2 |  |
 Bilirubin (mg/dL) | 2.2 ± 0.4 | 1.7 ± 0.3 | 2.8 ± 0.5 |  |
 Platelet (×1000/μL) | 203 ± 12.4 | 251 ± 14.3 | 153 ± 10.6 |  |
Positive blood cultures, n (%) | 75 (77.3) | 35 (68.6) | 40 (87.0) | Â |
ICU days, median (IQR) | 9 (5-14) | 8 (4-11) | 11 (7-16) | Â |
Length of stay, median (IQR) | 13 (8-18) | 11 (7-16) | 15 (9-19) | Â |